• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine (CAS 823188-79-0): A Versatile Chemical Building Block for Pharmaceutical Research

In the dynamic field of medicinal chemistry, N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine (CAS 823188-79-0) has emerged as a valuable intermediate with growing importance in drug discovery. This amine derivative features a unique molecular architecture combining a pyrrolidine ring with a benzylamine scaffold, making it particularly interesting for researchers developing central nervous system (CNS) targeting compounds and GPCR modulators.

The compound's structural characteristics contribute to its versatility in pharmaceutical applications. The N-methyl group enhances lipophilicity, while the pyrrolidine moiety offers conformational flexibility - both crucial factors in modern drug design. Recent studies highlight its potential as a precursor for dopamine receptor ligands and serotonin transporter inhibitors, addressing current research trends in neuropharmacology.

From a synthetic chemistry perspective, N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine demonstrates excellent reactivity in reductive amination and N-alkylation reactions. Its secondary amine functionality serves as an ideal handle for further derivatization, allowing medicinal chemists to explore diverse structure-activity relationships. The compound's moderate basicity (predicted pKa ~9.5) and balanced hydrophilicity make it particularly suitable for developing compounds with optimal blood-brain barrier penetration.

Current market analysis shows increasing demand for N-substituted benzylamine derivatives like CAS 823188-79-0, driven by pharmaceutical companies' focus on neurological disorders. The compound's structural similarity to approved drugs targeting Parkinson's disease and depression has sparked significant interest. Researchers are particularly exploring its potential in developing novel antidepressant candidates and cognitive enhancers, aligning with today's emphasis on mental health therapeutics.

Quality control of N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine typically involves HPLC analysis with UV detection, ensuring ≥98% purity for research applications. Proper storage under inert atmosphere at 2-8°C maintains stability, while characterization by 1H NMR and mass spectrometry confirms structural integrity. These quality assurance measures are critical for reproducible results in biological screening.

The growing importance of small molecule modulators in drug discovery has positioned CAS 823188-79-0 as a valuable tool for medicinal chemists. Its application extends beyond neurological targets to potential use in developing anti-inflammatory agents and metabolic disorder treatments, reflecting the compound's broad utility. Recent patent literature reveals innovative applications in allosteric modulator design, particularly for Class A GPCRs.

From a safety perspective, standard laboratory precautions are sufficient when handling N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine. While comprehensive toxicological data remains limited for this specific compound, structural analogs suggest moderate acute toxicity, warranting proper personal protective equipment. Researchers should consult material safety data sheets and implement appropriate ventilation when working with this material in powder form.

The synthesis of N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine typically involves a multi-step sequence starting from commercially available 4-aminobenzyl alcohol. Key steps include pyrrolidine introduction via nucleophilic substitution, followed by N-methylation of the resulting secondary amine. Process optimization has focused on improving yield and purity while minimizing environmental impact through green chemistry principles - a growing concern in pharmaceutical manufacturing.

Analytical characterization of CAS 823188-79-0 reveals distinct physicochemical properties: molecular weight of 204.29 g/mol, predicted logP of 2.1, and good solubility in common organic solvents (DMSO, ethanol, dichloromethane). These characteristics facilitate its use in diverse synthetic applications while ensuring compatibility with standard drug discovery workflows. The compound's UV chromophore (λmax ~260 nm) enables convenient analytical monitoring during chemical transformations.

Looking forward, N-Methyl-N-(4-pyrrolidin-1-ylbenzyl)amine is poised to maintain its relevance in pharmaceutical research. The continued exploration of neurological targets and GPCR-based therapies ensures ongoing demand for this versatile building block. Emerging applications in proteolysis targeting chimeras (PROTACs) and covalent inhibitor design further expand its potential utility, positioning CAS 823188-79-0 as a compound of sustained interest in medicinal chemistry.

• 397872-02-5(BENZENEMETHANAMINE, N,N-BIS[4-(1-PYRROLIDINYLMETHYL)PHENYL]-)
• 5468-68-8(4-[(butylamino)methyl]-N,N-diethylaniline)
• 828242-07-5(Benzenemethanamine,N-methyl-3-(1-pyrrolidinyl)-)
• 493-80-1(histapyrrodine)
• 402825-68-7(1,4-BENZENEDIAMINE, N-[[4-(1-PYRROLIDINYL)PHENYL]METHYL]-)
• 626216-51-1(N-(4-Diethylamino-benzyl)-N',N'-dimethyl-propane-1,3-diamine)
• 16183-28-1(Benzenemethanamine, N-butyl-4-(diethylamino)-)
• 175696-70-5(3-(Pyrrolidin-1-yl)benzylamine)
• 114365-04-7((4-(Pyrrolidin-1-yl)phenyl)methanamine)
• 187101-94-6(N-Benzyl-N-butyl-3-methylaniline)